Agomab Therapeutics raised €95M in a Series C round in Oct 2023. The company is based in Ghent, Belgium. Investors in the round: Fidelity Management & Research Company LLC. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €95M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
